( MENAFN - EIN Presswire) Next Generation diabetes Therapy and Drug Delivery market Report PORTLAND, OREGON, UNITED STATES, May 30, 2024 /EINPresswire / -- Allied Market Research has recently unveiled a research study titled "Next Generation Diabetes Therapy and Drug Delivery Market Outlook and Forecast 2020-2030." This report delivers a comprehensive analysis of market risks, spotlights opportunities, and provides essential support for strategic and tactical decision-making spanning from 2020 to 2030. The study categorizes the market by pivotal regions propelling its growth and commercialization.
Moreover, the report encompasses vital insights into market research and development, growth catalysts, and the evolving investment landscape within the Next Generation Diabetes Therapy and Drug Delivery Market. It also includes profiles of key industry players, such as Senseonics Holdings, Inc., Abbott laboratories, MannKind Corporation, Glysens Incorporated, Dexcom, Inc, Medtronic plc, Sanofi S.
A., Novo Nordisk A/S, Johnson & Johnson, Eli Lilly and Company Read More: Next Generation Diabetes Therapy and Drug Delivery Market Statistics: The global Next Generation Diabetes Therapy and Drug Delivery Market size was valued at $7.1 billion in 2020, and is projected to reach $28.
0 billion by 2030, growing at a CAGR of 14.28% from 2021 to 2030. Next Generation Diabetes Therapy and Drug Delivery Market Growth Drivers: Technological Advancements in Insulin Delivery Systems: The continuous .
